Tyler Laszewski
Impact in
- Oncology top 10%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Peptidase Inhibition and Analysis
- Immunology top 10%
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 3
- Cancer Immunotherapy and Biomarkers 2
- Peptidase Inhibition and Analysis 1
- Cytokine Signaling Pathways and Interactions 1
-
- Immunotherapy and Immune Responses 2
- Co-authors
- Sandra S. McAllister (4 shared papers)Molly J. DeCristo (3 shared papers)John N. Hutchinson (2 shared papers)Jessalyn M. Ubellacker (2 shared papers)Tiffany Tsang (1 shared paper)Whitney S. Henry (1 shared paper)Francisco Beça (1 shared paper)Alex Toker (1 shared paper)
- Journals
- PLoS Biology (1 paper)PLoS ONE (1 paper)Cancer Discovery (1 paper)Cancer Research (1 paper)Nature Cell Biology (1 paper)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Tyler Laszewski
6 papers receiving 583 citations
Peers
Comparison fields: 5 of 67
- Oncology 296
- Immunology 212
- Cancer Research 108
- Molecular Biology 223
- Physiology 11
Countries citing papers authored by Tyler Laszewski
This map shows the geographic impact of Tyler Laszewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tyler Laszewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tyler Laszewski more than expected).
Fields of papers citing papers by Tyler Laszewski
This network shows the impact of papers produced by Tyler Laszewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tyler Laszewski. The network helps show where Tyler Laszewski may publish in the future.
Co-authors
The 25 scholars most cited alongside Tyler Laszewski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 151 | |
| 2 | 2018 | 134 | |
| 3 | 2019 | 118 | |
| 4 | 2016 | 106 | |
| 5 | 2022 | 71 | |
| 6 | 2018 | 7 |
About Tyler Laszewski
Tyler Laszewski is a scholar working on Oncology, Immunology, Molecular Biology, Genetics and Pathology and Forensic Medicine, having authored 6 papers that have together received 587 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Pluripotent Stem Cells Research (1 paper), Histone Deacetylase Inhibitors Research (1 paper), Peptidase Inhibition and Analysis (1 paper), Metabolism, Diabetes, and Cancer (1 paper), Cancer Research and Treatments (1 paper) and Cytokine Signaling Pathways and Interactions (1 paper). The work is most often cited by research in Oncology (296 citations), Immunology (212 citations), Cancer Research (108 citations), Molecular Biology (223 citations) and Physiology (11 citations). Tyler Laszewski has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Sandra S. McAllister, Molly J. DeCristo, John N. Hutchinson, Jessalyn M. Ubellacker, Tiffany Tsang, Whitney S. Henry, Francisco Beça, Alex Toker, Andrew H. Beck and Glenn Dranoff. Their work appears in journals such as PLoS Biology, PLoS ONE, Cancer Discovery, Cancer Research and Nature Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.